The article discusses the growing trend of Hyperbaric Oxygen Therapy (HBOT) as a wellness treatment, but also highlights concerns about safety and regulation. HBOT is being marketed by spas, clinics, and wellness centers as a way to improve overall health and longevity, with some claims that it can even reverse certain diseases.
However, experts warn that not all HBOT treatments are created equal, and many facilities providing the therapy are not equipped with proper safety measures. Soft-sided chambers, in particular, have been identified as a risk due to their high pressure levels and potential for explosion or fire.
Tom Workman, a retired air force colonel and aerospace physiologist who has spent his retirement documenting unsafe HBOT practices, estimates that nearly 300 facilities in the US provide substandard care. He believes that the FDA should take an active role in regulating HBOT to ensure public safety, but notes that resources seem to be allocated to more high-profile problems.
Lawsuits can hold individual facilities accountable when incidents happen, but they do not provide broad protection for consumers. Some lawmakers have proposed mandating UHMS accreditation for facilities providing HBOT, which would ensure a minimum level of safety and standardization.
Experts advise anyone considering HBOT treatment to choose a center accredited by UHMS and to ask the right questions before undergoing treatment, such as whether they will be evaluated by a medical doctor, if the facility has an appointed safety coordinator on site, and if the technologists running their treatment have been properly trained and certified.
Ultimately, while HBOT may have some benefits, it is essential to approach this therapy with caution and to prioritize public safety.
However, experts warn that not all HBOT treatments are created equal, and many facilities providing the therapy are not equipped with proper safety measures. Soft-sided chambers, in particular, have been identified as a risk due to their high pressure levels and potential for explosion or fire.
Tom Workman, a retired air force colonel and aerospace physiologist who has spent his retirement documenting unsafe HBOT practices, estimates that nearly 300 facilities in the US provide substandard care. He believes that the FDA should take an active role in regulating HBOT to ensure public safety, but notes that resources seem to be allocated to more high-profile problems.
Lawsuits can hold individual facilities accountable when incidents happen, but they do not provide broad protection for consumers. Some lawmakers have proposed mandating UHMS accreditation for facilities providing HBOT, which would ensure a minimum level of safety and standardization.
Experts advise anyone considering HBOT treatment to choose a center accredited by UHMS and to ask the right questions before undergoing treatment, such as whether they will be evaluated by a medical doctor, if the facility has an appointed safety coordinator on site, and if the technologists running their treatment have been properly trained and certified.
Ultimately, while HBOT may have some benefits, it is essential to approach this therapy with caution and to prioritize public safety.